ADVISORY BOARD (NASDAQ:ABCO)
24.78
0.42 (1.67%)
| ADVISORY BOARD (NASDAQ:ABCO) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $25.20 | 52 Week High | $28.80 | ||
| Open | $25.01 | 52 Week Low | $13.45 | ||
| Day High | $25.32 | P/E | 32.61 | ||
| Day Low | $24.50 | EPS | $0.76 | ||
| Volume | 78,151 | ||||
| More ABCO Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| CPST | 2 | HAYN | 2 |
| LO | 1 | AFG | 1 |
| BRKS | 1 | LRN | 1 |
| ASEI | 1 | BZH | 1 |
| NYX | 1 | GNW | 1 |
| CELL | 1 | PPDI | 1 |
Entities who have mentioned ABCO
- Morgan Stanley | View Related Stories »
- Stock Buyback | View Related Stories »
- Jefferies & Co | View Related Stories »
- Merrill Lynch | View Related Stories »
- Stifel Nicolaus | View Related Stories »
- Barclays | View Related Stories »
- Trading Radar | View Related Stories »
- Dividend | View Related Stories »
- After-Hours Movers | View Related Stories »
- Deutsche Bank | View Related Stories »
View All Major News StreetInsider.com Major News for ABCO
- Advisory Board (ABCO) Reports Inline Q3 EPS of $0.26
- The Advisory Board Company (ABCO) Reports Mixed Q1 Results; Guides
- The Advisory Board Company (ABCO) Misses Street's Q1 Views; Reaffirms Forecast
View All ReportsStreetInsider.com Reports on ABCO
- Advisory Board (ABCO) Reports Inline Q3 EPS of $0.26
- Deutsche Bank Maintains a 'Hold' on Advisory Board Company (ABCO); Raises Price Target on Confident Outlook
- The Advisory Board Company (ABCO) Reports Mixed Q1 Results; Guides
- The Advisory Board Company (ABCO) Misses Street's Q1 Views; Reaffirms Forecast
- After-Hours Movers 2/9: AFG, WIRE, ASEI Higher; PFG, ZOLT, VRGY, HAYN, LNCR Lower
View All Press ReleasesCompany Press Releases on ABCO
- The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results
- The Advisory Board Company Schedules Second Quarter Conference Call for November 2, 2009
StreetInsider Reports on ABCO by Category
View All BlogsBlogs on ABCO
- The Advisory Board Company F2Q09 (Qtr End 09/30/08) Earnings Call Transcript
- Surmodics: Convergence of Devices and Drugs
Comments on ABCO
No comments are currently available.
